However, decreased PRDX4 repressed cell proliferation and triggered cell death pathways in hepatocellular carcinoma cell lines [15], suggesting the potential role of PRDX4 as activators or inhibitors in hepatocellular carcinoma with different stages and phenotypes. This evidence concerns the gene PRDX4 and hepatocellular carcinoma.